ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Artificial intelligence (AI)
  • Brain cancer
  • Breast cancer
  • ComboMATCH
  • COVID-19
  • Gastrointestinal (GI) cancer
  • Genitourinary (GU) cancer
  • Head and neck cancer
  • Health equity
  • Imaging
  • Immunotherapy
  • In memory
  • Leukemia
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Personalized treatment
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data
  • Real-world evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Young adults
July 24, 2025
July 24, 2025
Categories
  • Editorials

From caregiver to catalyst: Annie Achee is on a mission to raise awareness about sarcoma and advance research

In this interview, a champion for this rare cancer shares her journey and offers tips for seeking support
Do you like it?
0 Read more
July 24, 2025
July 24, 2025
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with sarcoma 

For Sarcoma Awareness Month, we highlight two actively recruiting clinical trials for patients with this rare cancer, which has had few treatment advances
Do you like it?
0 Read more
September 26, 2024
September 26, 2024
Categories
  • New Trials

Now Enrolling: The EA7222 clinical trial is testing a new treatment for patients with advanced soft tissue sarcoma

This study is for patients who have a type of soft tissue sarcoma, called undifferentiated pleomorphic sarcoma, that has spread to other areas in the body
Do you like it?
0 Read more
January 22, 2024
January 22, 2024
Categories
  • New Trials

Now Enrolling: The STRASS 2 study is testing a new treatment approach for patients with high-risk retroperitoneal sarcoma

This study is for patients who have soft tissue sarcoma in the abdomen or pelvis, behind the abdominal lining
Do you like it?
0 Read more

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc